Concurrent with the view that MET proteolysis likely results from an intrinsic cellular mechanism that attenuates excessive MET signaling [13], it was shown that MET ectodomain shedding augments with increased malignant potential by taking advantage of an in vitro derived breast cancer progression model, [40]. The gene discussed is MET; the disease is breast carcinoma.